In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided
Clinical trial demonstrates focused ultrasound can deliver antibody therapy to breast cancer metastases in the brain
